Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$39.32 - $61.61 $100,266 - $157,105
-2,550 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$44.0 - $65.8 $13,200 - $19,740
-300 Reduced 10.53%
2,550 $140,000
Q2 2021

Aug 12, 2021

SELL
$44.66 - $63.06 $49,125 - $69,366
-1,100 Reduced 27.85%
2,850 $136,000
Q1 2021

May 11, 2021

SELL
$46.31 - $62.7 $25,470 - $34,485
-550 Reduced 12.22%
3,950 $200,000
Q4 2020

Feb 11, 2021

SELL
$55.51 - $69.94 $5,551 - $6,994
-100 Reduced 2.17%
4,500 $283,000
Q3 2020

Nov 12, 2020

BUY
$42.19 - $69.61 $8,438 - $13,922
200 Added 4.55%
4,600 $309,000
Q2 2020

Aug 10, 2020

BUY
$27.55 - $43.28 $11,020 - $17,312
400 Added 10.0%
4,400 $184,000
Q1 2020

May 07, 2020

BUY
$23.16 - $47.8 $11,580 - $23,900
500 Added 14.29%
4,000 $126,000
Q4 2019

Feb 10, 2020

BUY
$27.97 - $40.38 $97,895 - $141,330
3,500 New
3,500 $141,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.